“…The above side-effects can be abated by encapsulation of a minimal drug dosage into a biocompatible drug carrier. Of this, 5FU has been encapsulated in many drug carrier platform, such as, chitosan [ 18 ] and cellulose [ 19 , 20 ]. In this matter, some polysaccharides, including cellulose, chitosan, starch, xanthan gum, hyaluronic acid, and carrageenans can display pH/thermos-responsive properties to control the drug release dosage with effective anticancer actions [ 21 ].…”